Phosphoinositide-3 Kinase Inhibitors
- Name
- Phosphoinositide-3 Kinase Inhibitors
- Accession Number
- DBCAT005566
- Description
Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity.
- Drugs
Drug Drug Description Tenalisib Tenalisib is under investigation in clinical trial NCT03711604 (Compassionate Use Study of Tenalisib (RP6530)). Inavolisib Inavolisib (GDC-0077) is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine... - Drugs & Drug Targets
Drug Target Type